Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic, works by slowing stomach emptying and signaling fullness to your brain—a mechanism that clinical trials show produces average weight loss of 15% of body weight over 68 weeks. Before choosing this medication, it's important to weigh the documented advantages against potential drawbacks and explore whether compounded alternatives might offer the same benefits at lower cost.
How Semaglutide Works for Weight Loss
Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone your gut produces after eating. When activated, GLP-1 receptors reduce appetite, increase feelings of fullness, and slow the rate at which food moves through your stomach. This combination of effects leads to reduced calorie intake without requiring restrictive dieting.
The medication also appears to influence reward pathways in the brain related to food cravings, which may help reduce emotional eating patterns. Studies in the New England Journal of Medicine demonstrated that participants taking semaglutide lost significantly more weight than those on placebo, with benefits appearing as early as four weeks into treatment.
Key Advantages of Semaglutide Treatment
The primary advantage of semaglutide is its proven clinical effectiveness—it consistently outperforms diet and exercise alone for sustained weight loss. For people with type 2 diabetes, semaglutide also improves blood sugar control, reduces cardiovascular disease risk, and may lower blood pressure, offering benefits beyond weight reduction.
Semaglutide is administered once weekly via injection, making compliance simpler than daily oral medications. Many patients report improved energy levels, better blood sugar stability, and reduced food preoccupation after starting treatment, which can improve overall quality of life during their weight loss journey.
Common Side Effects and Limitations
Gastrointestinal side effects are the most frequently reported drawbacks, including nausea, vomiting, constipation, and diarrhea. These effects tend to be most pronounced when starting treatment or increasing the dose, and they often improve within days or weeks as your body adjusts. Some patients experience persistent mild nausea that requires dose adjustment or medication to manage comfortably.
Weight regain is a significant consideration—clinical evidence shows that stopping semaglutide typically results in gradual weight return within months. This means the medication works best as part of a long-term treatment plan rather than a short-term intervention. Additionally, semaglutide requires ongoing use to maintain results, making cost and accessibility important factors in your decision.
Cost Comparison: Brand Ozempic vs. Compounded Semaglutide
Brand-name Ozempic typically costs $900 to $1,300 per month without insurance, placing it out of reach for many patients. Since most insurance companies require prior authorization and often deny coverage for weight loss alone, out-of-pocket expenses remain the reality for many people seeking this treatment.
Compounded semaglutide from licensed 503A pharmacies offers the same active ingredient at significantly lower cost—PlexusDx's Compounded Semaglutide Injection starts at $149 per month, with your dose increasing as needed while your price remains flat. PlexusDx serves all 50 states, accepts HSA and FSA funds, and requires no insurance or membership fees, making this medication accessible to patients across different financial situations.
Is Semaglutide Right for Your Weight Loss Goals?
Semaglutide works best for people with a BMI over 27 who have not achieved lasting results with lifestyle changes alone, or those with weight-related health conditions like type 2 diabetes. Certain medical conditions, including a personal or family history of thyroid cancer or multiple endocrine neoplasia, make semaglutide inappropriate, so medical screening is essential before starting.
Your genetic makeup also influences how effectively you'll respond to semaglutide. PlexusDx's Precision Peptide Genetic Test identifies your unique GLP-1 receptor variants (like rs6923761) and other peptide-pathway genes across 14 pathways, helping your provider predict whether semaglutide will be highly effective for you or whether alternative medications might work better. This personalized approach takes the guesswork out of choosing the right medication for your body.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can you realistically expect to lose with semaglutide?
Clinical trials show average weight loss of 15% of body weight over 68 weeks, with some patients losing up to 20%. Individual results vary significantly based on genetics, lifestyle, dose, and how long you've been taking the medication. PlexusDx's genetic testing helps predict your expected response range.
How long does it take for semaglutide to work?
Most people notice reduced appetite and appetite-related weight loss within the first two to four weeks of starting semaglutide. Maximum effects typically appear at eight to twelve weeks as your body adjusts and your dose reaches therapeutic levels.
Can I use my HSA or FSA with PlexusDx semaglutide?
Yes. PlexusDx's Compounded Semaglutide Injection is HSA and FSA eligible, and costs start at just $149 per month. All medications come from licensed 503A compounding pharmacies, require no insurance, and are available in all 50 states.
What happens to your weight after you stop taking semaglutide?
Research shows most people gradually regain weight within six to twelve months of stopping semaglutide, typically regaining 50% or more of the weight lost. This is why semaglutide is most effective as a long-term maintenance medication rather than a temporary fix.
How does genetic testing help predict semaglutide success?
PlexusDx's Precision Peptide Genetic Test examines your GLP1R gene variant (rs6923761) and other peptide-pathway variants across 49 peptides to estimate your likely response to semaglutide. This personalized insight helps your provider choose the medication most likely to work for your unique biology at the lowest effective dose.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where on My Thigh Can I Inject Ozempic?
Where on My Thigh Can I Inject Ozempic?